SLC16A1 and pancreatic ductal adenocarcinoma: Pancreatic ductal adenocarcinoma (PDAC) progression can be halted by miR-124 modulation that targets monocarboxylate transporter-1 (MCT-1), integrin α3 (ITGA3), and integrin β1 (ITGB1).